Apellis Pharmaceuticals, Inc. (APLS) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, the three largest insider holders of APLS are Venture Investments Ltd Morningside (TenPercentOwner, 12.81Mn shares), Pascal Deschatelets (Chief Scientific Officer, 1.18Mn shares), Cedric Francois (Chief Executive Officer, 490.84K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Venture Investments Ltd Morningside 12,806,342 0 18 Nov, 2021
Pascal Deschatelets Chief Scientific Officer 1,177,222 0 30 Jan, 2026
Cedric Francois Chief Executive Officer 425,968 372,815 13 Mar, 2026
Alec Machiels 384,989 0 05 Jan, 2026
A. Sinclair Dunlop 161,567 0 05 Jan, 2026
Timothy Eugene Sullivan Chief Financial Officer 152,041 0 30 Jan, 2026
David O. Watson General Counsel 144,517 0 30 Jan, 2026
Kelley Boucher Chief People Officer 127,804 0 30 Jan, 2026
Nur Nicholson Chief Technical Officer 116,338 0 30 Jan, 2026
Mark Jeffrey Delong Chief Business Strat Officer 114,591 0 13 Feb, 2026
Leslie Meltzer Chief Research And Development 107,024 0 30 Jan, 2026
Federico Grossi Chief Medical Officer 94,884 0 09 Jan, 2023
Caroline Baumal Chief Medical Officer 86,527 0 23 Jan, 2026
Adam J. Townsend Chief Commercial Officer 84,050 0 30 Jan, 2025
Karen Lewis Chief People Officer 70,251 0 30 Jan, 2025
Lukas Scheibler Chief Research Officer 68,299 0 05 Dec, 2023
James George Chopas Vp/Chief Accounting Officer 65,955 0 30 Jan, 2026
Timothy Eugene Sullivan Chief Financial Officer 0 60,396 10 Sep, 2025
Jeffrey Eisele Chief Development Officer 55,312 0 30 Jan, 2025
David O. Watson General Counsel 0 50,136 12 Sep, 2025
Paul R. Fonteyne 30,666 0 05 Jan, 2026
A. Sinclair Dunlop 0 30,142 02 Oct, 2025
Gerald Chan 25,666 0 05 Jan, 2026
Stephanie Monaghan O'Brien 25,666 0 05 Jan, 2026
Craig A Wheeler 24,444 0 05 Jan, 2026
Victoria L. Brown Program Team Lead 23,556 0 24 Jan, 2023
Keli Walbert 17,051 0 05 Jan, 2026
Mikael Dolsten 14,312 0 03 Mar, 2026
Nicole D Perry Vice President Accounting 4,847 0 03 Aug, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
11 Mar, 2026 Cedric Francois Common Stock D 64,869 $0.00 425,968 D G
11 Mar, 2026 Cedric Francois Common Stock A 64,869 $0.00 372,815 I G
27 Feb, 2026 Mikael Dolsten Common Stock A 14,312 $0.00 14,312 D A
27 Feb, 2026 Mikael Dolsten Stock Option (Right to Buy) A 24,135 $20.96 24,135 D A
11 Feb, 2026 Mark Jeffrey Delong Common Stock D 368 $22.15 114,591 D S
03 Feb, 2026 Cedric Francois Common Stock A 8,840 $3.76 490,837 D M
03 Feb, 2026 Cedric Francois Stock Option (Right to Buy) D 8,840 $0.00 0 D M
28 Jan, 2026 Kelley Boucher Common Stock A 30,146 $0.00 127,804 D A
28 Jan, 2026 Pascal Deschatelets Common Stock A 25,840 $0.00 1,177,222 D A
28 Jan, 2026 David O. Watson Common Stock A 55,986 $0.00 144,517 D A
28 Jan, 2026 Timothy Eugene Sullivan Common Stock A 58,140 $0.00 152,041 D A
28 Jan, 2026 James George Chopas Common Stock A 16,150 $0.00 65,955 D A
28 Jan, 2026 Leslie Meltzer Common Stock A 45,220 $0.00 107,024 D A
28 Jan, 2026 Mark Jeffrey Delong Common Stock A 36,606 $0.00 114,959 D A
28 Jan, 2026 Nur Nicholson Common Stock A 45,220 $0.00 116,338 D A
28 Jan, 2026 Cedric Francois Common Stock A 195,952 $0.00 481,997 D A
22 Jan, 2026 Timothy Eugene Sullivan Common Stock D 10,287 $21.77 93,901 D S
22 Jan, 2026 Mark Jeffrey Delong Common Stock D 3,371 $21.77 78,353 D S
22 Jan, 2026 Cedric Francois Common Stock D 27,192 $21.77 286,045 D S
22 Jan, 2026 Nur Nicholson Common Stock D 7,725 $21.77 71,118 D S